Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

The Impact of Different Ethical Allocation Strategies on Survival during Vincristine Shortages

Andrew Hantel, MD, Michael McManus, MD MPH, Gregory A. Abel, MD MPH

Blood (2020) 136 (Supplement 1): 59–60.

https://doi.org/10.1182/blood-2020-136643

Published: 2020

Journal Articles

Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-140317

Published: 2020

Journal Articles

Pre-Diagnostic and Cancer-Associated Depression and Anxiety Among Patients with Hematologic Malignancies in the United States

Thomas M. Kuczmarski, MD, Tim Jaung, MS, Claire E. Mancuso, BS, Lizabeth Roemer, PhD, Gregory A. Abel, MD MPH, Oreofe O. Odejide, MDMPH

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-140151

Published: 2020

Journal Articles

Feasibility of Peri-Transfusion Quality of Life Assessment for Patients with Myelodysplastic Syndromes

Gregory A. Abel, MD MPH, Heidi D. Klepin, MDMS, Emily S. Magnavita, MPH, Tim Jaung, MS, Rory M. Shallis, MD, Nupur E. Bahl, Rebecca Dellinger-Johnston, Eric S. Winer, MD, Amer M. Zeidan, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-139919

Published: 2020

Journal Articles

Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study

Gregory A. Abel, MD MPH, Donnie Hebert, PhD, Cecilia Lee, DrPH, RN, James M. Foran, MD, Steven D. Gore, MD, Wael Saber, MD MS, Dana Elise Rollison, PhD, Eric Padron, MD, Steffanie H. Wilson, PhD, Jason Thompson, MS, MBA, Myron Waclawiw, PhD, Nancy L. DiFronzo, PhD, Mikkael A. Sekeres

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-136992

Published: 2020

Journal Articles

Potential Barriers to Clinical Trials of New Therapeutics for Myelodysplastic Syndromes: Wide Variation in Risk Definitions and Trial Enrollment Criteria

Andrew M. Brunner, MD, Jacqueline S. Garcia, R. Coleman Lindsley, MD, PhD, Gregory A. Abel, MD MPH, Donna S Neuberg, ScD, Richard M. Stone, MD, Timothy A. Graubert, MD, David P. Steensma, MD

Blood (2018) 132 (Supplement 1): 4378.

https://doi.org/10.1182/blood-2018-99-114356

Published: 2018

Journal Articles

Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study

Ling Zhang, MD, Donald M Stablein, PhD, Pearlie Epling-Burnette, PhD PharmD, Alexandra M. Harrington, MDMT(ASCP), Lynn C. Moscinski, MD, Steven Kroft, MD, Amy E. DeZern, MD, Tareq Al Baghdadi, MD, Jane Jijun Liu, MD, Matthew J. Walter, MD, Rafael Bejar, MD PhD, Edward J. Gorak, DO, MBA, MS, Rami S. Komrokji, MD, Gregory A. Abel, MD MPH, Bart L Scott, MD, Steven D. Gore, MD, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 4370.

https://doi.org/10.1182/blood-2018-99-116629

Published: 2018

Journal Articles

Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)

Samuel Slavin, MD, Andrew M. Brunner, MD, David P. Steensma, MD, Amir T. Fathi, MD, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD, Gregory A. Abel, MD MPH, Areej El-Jawahri, MD

Blood (2018) 132 (Supplement 1): 4750.

https://doi.org/10.1182/blood-2018-99-116434

Published: 2018

Journal Articles

Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML)

Areej El-Jawahri, MD, Lauren Waldman, BA, Joseph Greer, PhD, Gregory A. Abel, MD MPH, David P. Steensma, MD, Andrew M. Brunner, MD, Amir T. Fathi, MD, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD

Blood (2018) 132 (Supplement 1): 2291.

https://doi.org/10.1182/blood-2018-99-114246

Published: 2018

Journal Articles

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Rahul S. Vedula, MD, Marlise R. Luskin, MD, Kevin Copson, MA, Priti Kumari, M.S., Anne Charles, BS, Annette S. Kim, MD PhD, Elizabeth A Morgan, MD, Gregory A. Abel, MD MPH, Richard M. Stone, MD, Andrew A. Lane, MD PhD, R. Coleman Lindsley, MD, PhD

Blood (2018) 132 (Supplement 1): 1819.

https://doi.org/10.1182/blood-2018-99-118746

Published: 2018

Journal Articles

Patient-Reported Outcomes Associated with Different Treatments for Myelodysplastic Syndromes

Marlise R. Luskin, MD MSCE, Angel M. Cronin, MS, Martha Wadleigh, MD, David P. Steensma, MD, Richard M. Stone, MD, Daniel J. DeAngelo, MD PhD, Gregory A. Abel, MD MPH

Blood (2016) 128 (22): 3602.

https://doi.org/10.1182/blood.V128.22.3602.3602

Published: 2016

Journal Articles

Measurement and Prevalence of Cognitive Impairment in Older Patients with Hematologic Malignancies

Tammy T. Hshieh, MD MPH, Nolan B. Condron, BA, Richard M. Stone, MD, Robert J. Soiffer, MD, Gregory A. Abel, MD MPH

Blood (2016) 128 (22): 689.

https://doi.org/10.1182/blood.V128.22.689.689

Published: 2016

Journal Articles

Cost-Effectiveness Analysis of Warfarin Versus Low-Molecular Weight Heparin for the Treatment of Malignancy-Associated Venous Thromboembolism

Nathan T. Connell, MD, M.P.H., Gregory A. Abel, MD MPH, Jean M. Connors, MD

Blood (2015) 126 (23): 746.

https://doi.org/10.1182/blood.V126.23.746.746

Published: 2015

Journal Articles

Quality of End-of-Life Care for the Myelodysplastic Syndromes: Findings from a Large National Database

Sean A. Fletcher, Angel M. Cronin, MS, Amer M. Zeidan, MBBS, MHS, Oreofe O. Odejide, MD, Steven D. Gore, MD, Amy J. Davidoff, PhD, David P. Steensma, MD, Gregory A. Abel, MD MPH

Blood (2015) 126 (23): 3287.

https://doi.org/10.1182/blood.V126.23.3287.3287

Published: 2015

Journal Articles

Measuring Quality of End-of-Life Care for Blood Cancers: A National Survey of Hematologic Oncologists

Oreofe O. Odejide, MD, Angel M. Cronin, Nolan B. Condron, Sean A. Fletcher, Craig Earle, MD, Gregory A. Abel, MD MPH

Blood (2015) 126 (23): 3290.

https://doi.org/10.1182/blood.V126.23.3290.3290

Published: 2015

Journal Articles

Feasibility of Routine Frailty Screening Assessment for Patients in a Hematologic Oncology Clinic: Results from a Pilot Study

Gregory A. Abel, MD MPH, Tammy T. Hshieh, MD, Nolan B. Condron, Caron A. Jacobson, MD, David P. Steensma, MD, Jacob P. Laubach, MD, Richard M. Stone, MD, Jane A. Driver, MD MPH

Blood (2015) 126 (23): 3306.

https://doi.org/10.1182/blood.V126.23.3306.3306

Published: 2015

Journal Articles

Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit

Tanya Keenan, MD, Thomas W. LeBlanc, MD MA, Lara Traeger, PhD, Harry Vandusen, BS, Gregory A. Abel, MD MPH, David P. Steensma, MD, Amir T. Fathi, MD, Daniel J DeAngelo, MD PhD, Martha Wadleigh, MD, Gabriela Hobbs, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Karen K. Ballen, MD, Yi-Bin Chen, MD, Jennifer S. Temel, MD, Areej El-Jawahri, MD

Blood (2015) 126 (23): 2104.

https://doi.org/10.1182/blood.V126.23.2104.2104

Published: 2015

Journal Articles

High Body Mass Index (BMI) in North American Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab (R)-CHOP Compensates for Negative Impact of Male Gender

Zheng Zhou, MD PhD, Alfred W. Rademaker, PhD, Leo I. Gordon, MD, Ann S. LaCasce, MD, Allison Crosby-Thompson, Ann Vanderplas, MS, Gregory A Abel, MD MPH, Maria A. Rodriguez, MD, Auayporn Nademanee, MD, Mark Kaminski, Myron S. Czuczman, MD, Michael M. Millenson, MD, Joyce Niland, PhD, Andrew D. Zelenetz, MD PhD, Jonathan W. Friedberg, MD, Jane N. Winter, MD

Blood (2014) 124 (21): 3046.

https://doi.org/10.1182/blood.V124.21.3046.3046

Published: 2014

Journal Articles

Predictors of Hospice Utilization Among Patients with Lymphoma

Oreofe O. Odejide, MD, Angel M. Cronin, MS, Ann LaCasce, MD, Gregory A. Abel, MD MPH

Blood (2014) 124 (21): 558.

https://doi.org/10.1182/blood.V124.21.558.558

Published: 2014

Journal Articles

Preliminary International Validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

Gregory A. Abel, MD MPH, Fabio Efficace, PhD, Rena Buckstein, MD, Sara Tinsley, ARNP, Joseph G. Jurcic, MD, Yolanda Martins, PhD, David P. Steensma, MD, Corey D Watts, Azra Raza, MD, Alan F. List, MD, Robert J. Klaassen, MD FRCP

Blood (2014) 124 (21): 1328.

https://doi.org/10.1182/blood.V124.21.1328.1328

Published: 2014

NARROW

The Impact of Different Ethical Allocation Strategies on Survival during Vincristine Shortages

Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS

Pre-Diagnostic and Cancer-Associated Depression and Anxiety Among Patients with Hematologic Malignancies in the United States

Feasibility of Peri-Transfusion Quality of Life Assessment for Patients with Myelodysplastic Syndromes

Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study

Potential Barriers to Clinical Trials of New Therapeutics for Myelodysplastic Syndromes: Wide Variation in Risk Definitions and Trial Enrollment Criteria

Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study

Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)

Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML)

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Patient-Reported Outcomes Associated with Different Treatments for Myelodysplastic Syndromes

Measurement and Prevalence of Cognitive Impairment in Older Patients with Hematologic Malignancies

Cost-Effectiveness Analysis of Warfarin Versus Low-Molecular Weight Heparin for the Treatment of Malignancy-Associated Venous Thromboembolism

Quality of End-of-Life Care for the Myelodysplastic Syndromes: Findings from a Large National Database

Measuring Quality of End-of-Life Care for Blood Cancers: A National Survey of Hematologic Oncologists

Feasibility of Routine Frailty Screening Assessment for Patients in a Hematologic Oncology Clinic: Results from a Pilot Study

Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit

High Body Mass Index (BMI) in North American Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab (R)-CHOP Compensates for Negative Impact of Male Gender

Predictors of Hospice Utilization Among Patients with Lymphoma

Preliminary International Validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only